Tafi Andrea, Costi Roberta, Botta Maurizio, Di Santo Roberto, Corelli Federico, Massa Silvio, Ciacci Andrea, Manetti Fabrizio, Artico Marino
Dipartimento Farmaco Chimico Tecnologico, Università di Siena, Via Aldo Moro, S. Miniato, I-53100 Siena, Italy.
J Med Chem. 2002 Jun 20;45(13):2720-32. doi: 10.1021/jm011087h.
The synthesis, anti-Candida activity, and quantitative structure-activity relationship (QSAR) studies of a series of 2,4-dichlorobenzylimidazole derivatives having a phenylpyrrole moiety (related to the antibiotic pyrrolnitrin) in the alpha-position are reported. A number of substituents on the phenyl ring, ranging from hydrophobic (tert-butyl, phenyl, or 1-pyrrolyl moiety) to basic (NH(2)), polar (CF(3), CN, SCH(3), NO(2)), or hydrogen bond donors and acceptor (OH) groups, were chosen to better understand the interaction of these compounds with cytochrome P450 14-alpha-lanosterol demethylase (P450(14DM)). Finally, the triazole counterpart of one of the imidazole compounds was synthesized and tested to investigate influence of the heterocyclic ring on biological activity. The in vitro antifungal activities of the newly synthesized azoles 10p-v,x-c' were tested against Candida albicans and Candida spp. at pH 7.2 and pH 5.6. A CoMFA model, previously derived for a series of antifungal agents belonging to chemically diverse families related to bifonazole, was applied to the new products. Because the results produced by this approach were not encouraging, Catalyst software was chosen to perform a new 3D-QSAR study. Catalyst was preferred this time because of the possibility of considering each compound as a collection of energetically reasonable conformations and of considering alternative stereoisomers. The pharmacophore model developed by Catalyst, named HYPO1, showed good performances in predicting the biological activity data, although it did not exhibit an unequivocal preference for one enantiomeric series of inhibitors relative to the other. One aromatic nitrogen with a lone pair in the ring plane (mapped by all of the considered compounds) and three aromatic ring features were recognized to have pharmacophoric relevance, whereas neither hydrogen bond acceptor nor hydrophobic features were found. These findings confirmed that the key interaction of azole antifungals with the demethylase enzyme is the coordination bond to the iron ion of the porphyrin system, while interactions with amino acids localized in proximity of heme could modulate the biological activity of diverse antifungal agents. In conclusion, HYPO1 conveys important information in an intuitive manner and can provide predictive capability for evaluating new compounds.
报道了一系列在α-位具有苯基吡咯部分(与抗生素吡咯菌素相关)的2,4-二氯苄基咪唑衍生物的合成、抗念珠菌活性及定量构效关系(QSAR)研究。在苯环上选择了许多取代基,范围从疏水的(叔丁基、苯基或1-吡咯基部分)到碱性的(NH₂)、极性的(CF₃、CN、SCH₃、NO₂)或氢键供体和受体(OH)基团,以更好地理解这些化合物与细胞色素P450 14-α-羊毛甾醇脱甲基酶(P450(14DM))的相互作用。最后,合成并测试了其中一种咪唑化合物的三唑类似物,以研究杂环对生物活性的影响。在pH 7.2和pH 5.6条件下,测试了新合成的唑类化合物10p-v,x-c'对白色念珠菌和念珠菌属的体外抗真菌活性。将先前为一系列与联苯苄唑相关的化学结构不同的抗真菌剂推导的CoMFA模型应用于这些新产品。由于这种方法得到的结果并不理想,因此选择Catalyst软件进行新的3D-QSAR研究。这次选择Catalyst是因为有可能将每个化合物视为一系列能量合理的构象集合,并考虑替代的立体异构体。由Catalyst开发的药效团模型HYPO1在预测生物活性数据方面表现良好,尽管它对于一种对映体系列抑制剂相对于另一种对映体系列抑制剂并没有明确的偏好。在环平面内具有孤对电子的一个芳香氮(所有考虑的化合物都映射到)和三个芳香环特征被认为具有药效团相关性,而未发现氢键受体或疏水特征。这些发现证实,唑类抗真菌剂与脱甲基酶的关键相互作用是与卟啉系统铁离子的配位键,而与血红素附近定位的氨基酸的相互作用可以调节不同抗真菌剂的生物活性。总之,HYPO1以直观的方式传达重要信息,并可为评估新化合物提供预测能力。